Pharmateca
ISSN 2073-4034 (Print)
ISSN 2414-9128 (Online)
Menu
Arquivos
Página principal
Sobre a Revista
Política Editorial
Diretrizes para Autores
Sobre a Revista
Edições
Pesquisa
Edição corrente
Artigos retraídos
Arquivos
Contatos
Assinatura
Editorial Board
Todas as revistas
Usuário
Nome de usuário
Senha
Lembrar usuário
Esqueceu a senha?
Cadastro
Notificações
Ver
Assinar
Assinatura
Entrar no sistema para verificar sua assinatura
Conteúdo da revista
Pesquisa
Escopo da Busca
Todos
Autores
Título
Resumo
Termos
Texto integral
Navegar
Edições
Autores
por título
Outras Revistas
Categorias
Palavras-chave
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
×
Usuário
Nome de usuário
Senha
Lembrar usuário
Esqueceu a senha?
Cadastro
Notificações
Ver
Assinar
Assinatura
Entrar no sistema para verificar sua assinatura
Conteúdo da revista
Pesquisa
Escopo da Busca
Todos
Autores
Título
Resumo
Termos
Texto integral
Navegar
Edições
Autores
por título
Outras Revistas
Categorias
Palavras-chave
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
Página principal
>
Pesquisa
>
Informaçao sobre o Autor
Informaçao sobre o Autor
Sychev, D. A
Edição
Seção
Título
Arquivo
Nº 13 (2015)
Articles
Chastota naznacheniya potentsial'no ne rekomendovannykh lekarstvennykh preparatov (po kriteriyam «STOPP START») pozhilym patsientam, nakhodyashchimsya v terapevticheskikh otdeleniyakh statsionara: rezul'taty farmakoepidemiologicheskogo issledovaniya
Volume 27, Nº 5 (2020)
Articles
«PharmaCOVID» - information center for pharmacotherapy of patients with new coronavirus infection COVID-19
Volume 27, Nº 5 (2020)
Articles
Drug-induced diseases: epidemiology and urgency of the problem
Volume 27, Nº 6 (2020)
Articles
Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance
Volume 27, Nº 14 (2020)
Articles
Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19
Volume 28, Nº 1 (2021)
Articles
The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide
Volume 28, Nº 1 (2021)
Articles
Possibility and prospects of using bamlanivimab in patients with COVID-19
Volume 28, Nº 3 (2021)
Articles
Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system
Volume 28, Nº 3 (2021)
Articles
The influence of CYP2C9 gene polymorphisms on the efficacy of losartan in patients with grade I-II arterial hypertension
Volume 28, Nº 3 (2021)
Articles
Carriage of the COMT rs4680 polymorphic variant is associated with better tolerance to antipsychotics in adolescents with an acute psychotic episode: a prospective observational clinical study
Volume 28, Nº 5 (2021)
Articles
Tobacco smoking as a risk factor for the development of drug-induced diseases
Volume 28, Nº 9 (2021)
Articles
Polymorphic variants of the ANKS1B rs7968606 (C>T) and ZNF804A rs1344706 (G>T) genes are not associated with the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
Volume 28, Nº 9 (2021)
Articles
HTR2A rs6313 polymorphic variant is associated with adverse effects to antipsychotics in adolescents with an acute psychotic episode
Volume 28, Nº 10 (2021)
Articles
Potentials for the use of glucocorticosteroids in inpatients with severe COVID-19
Volume 28, Nº 11 (2021)
Articles
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors
Volume 28, Nº 11 (2021)
Articles
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
Volume 28, Nº 11 (2021)
Articles
Medication errors as risk factor for drug-induced diseases
Volume 28, Nº 12 (2021)
Articles
Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19
Volume 28, Nº 12 (2021)
Articles
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
Volume 28, Nº 13 (2021)
Articles
Drug-alcohol interactions: focus on central-acting drugs and analgesics
Volume 28, Nº 13 (2021)
Articles
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs
Volume 28, Nº 13 (2021)
Articles
Effect of CYP2C9 gene polymorphism on losartan dosage regimen in patients with I-II degree arterial hypertension
Volume 29, Nº 1 (2022)
Articles
Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions
Volume 29, Nº 3 (2022)
Articles
Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence
Volume 29, Nº 3 (2022)
Articles
Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status
Volume 29, Nº 13 (2022)
Articles
Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins
Este site utiliza cookies
Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.
Informação sobre cookies
TOP